Tectonic Therapeutic (TECX) EBIT (2017 - 2026)
Tectonic Therapeutic (TECX) reported EBIT of -$27.3 million for Q1 2026, down 49.2% year-over-year from -$53.7 million in Q1 2025, and down 26.89% quarter-over-quarter from -$21.5 million in Q4 2025.
Tectonic Therapeutic (TECX) EBIT (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of EBIT data on file, last reported at -$27.3 million in Q1 2026.
- EBIT for Q1 2026 came in at -$27.3 million, down 49.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$93.0 million (down 46.87% YoY), and the FY2025 annual result was -$84.0 million, down 44.85% from the prior year.
- EBIT fell to -$27.3 million in Q1 2026 per TECX's latest filing, from -$21.5 million in the prior quarter.
- Over five years, EBIT peaked at -$9.4 million in Q4 2023 and troughed at -$29.4 million in Q1 2022.
- A 5-year average of -$19.4 million and a median of -$21.5 million in 2025 frame the typical range for EBIT.
- The sharpest annual moves came in 2023 and 2025: EBIT soared 62.89% in 2023, then plunged 95.53% in 2025.
- A 5-year view of EBIT shows it stood at -$25.3 million in 2022, then soared by 62.89% to -$9.4 million in 2023, then tumbled by 49.25% to -$14.0 million in 2024, then slumped by 53.78% to -$21.5 million in 2025, then retreated by 26.89% to -$27.3 million in 2026.
- Business Quant data shows TECX's EBIT at -$27.3 million in Q1 2026, -$21.5 million in Q4 2025, and -$21.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -65.83 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -27.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.30 Mn |
| Dec 31, 2025 | -21.52 Mn |
| Sep 30, 2025 | -21.89 Mn |
| Jun 30, 2025 | -22.33 Mn |
| Mar 31, 2025 | -18.30 Mn |
| Dec 31, 2024 | -13.99 Mn |
| Sep 30, 2024 | -19.64 Mn |
| Jun 30, 2024 | -11.42 Mn |
| Mar 31, 2024 | -12.97 Mn |
| Dec 31, 2023 | -9.37 Mn |
| Sep 30, 2023 | -10.11 Mn |
| Jun 30, 2023 | -10.63 Mn |
| Mar 31, 2023 | -25.22 Mn |
| Dec 31, 2022 | -25.26 Mn |
| Sep 30, 2022 | -22.99 Mn |
| Jun 30, 2022 | -27.77 Mn |
| Mar 31, 2022 | -29.42 Mn |
| Dec 31, 2021 | -27.96 Mn |
| Sep 30, 2021 | -32.62 Mn |
| Jun 30, 2021 | -31.38 Mn |